Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has provided an announcement.
Proteomics International Laboratories Ltd announced the issuance of 675,674 unquoted equity securities, specifically options expiring on May 31, 2026, with an exercise price of $0.50. This issuance is part of the company’s ongoing financial strategies and may impact its market positioning by potentially increasing its capital base, thereby supporting its operational and strategic initiatives.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves the large-scale study of proteins, particularly their structures and functions, and is aimed at improving healthcare outcomes.
Average Trading Volume: 147,943
Technical Sentiment Signal: Sell
Current Market Cap: A$56.73M
For detailed information about PIQ stock, go to TipRanks’ Stock Analysis page.